Skip to contents

Norman K. Hollenberg, MD, PhD
Radiologist, Brigham and Women's Hospital
Professor of Radiology, Harvard Medical School

Brigham and Women's Hospital
Department of Radiology
75 Francis Street
Boston, MA 02115

Edit Profile


Publications (Pulled from Harvard Catalyst Profiles):

1. Barkoudah E, van Thiel BS, Fisher ND, Gregg RA, Danser AH, Moukarbel GV, Hollenberg NK. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren. J Hypertens. 2016 May; 34(5):935-41.

2. Fisher ND, Hurwitz S, Hollenberg NK. Habitual flavonoid intake and endothelial function in healthy humans. J Am Coll Nutr. 2012 Aug; 31(4):275-9.

3. Hollenberg NK. Is there room for dual blockade of the renin-angiotensin-aldosterone system? J Hypertens. 2012 Apr; 30(4):671-2.

4. Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH. Impact of glycaemic control on the effect of direct renin inhibition in the AVOID study. J Renin Angiotensin Aldosterone Syst. 2012 Jun; 13(2):250-3.

5. Hollenberg NK. Flavonoids [corrected] and blood pressure. Am J Clin Nutr. 2012 Feb; 95(2):271.

6. Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens. 2011 Dec; 29(12):2454-61.

7. Krop M, van Gool JM, Day D, Hollenberg NK, Jan Danser AH. Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment. J Hypertens. 2011 Nov; 29(11):2138-46.

8. Saxena AR, Ananth Karumanchi S, Fan SL, Horowitz GL, Hollenberg NK, Graves SW, Seely EW. Correlation of cystatin-C with glomerular filtration rate by inulin clearance in pregnancy. Hypertens Pregnancy. 2012; 31(1):22-30.

9. Weir MR, Hollenberg NK, Remuzzi G, Zappe DH, Meng X, Parving HH. Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patients. J Hypertens. 2011 Oct; 29(10):2031-7.

10. Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Hans-Henrik P. Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy. J Renin Angiotensin Aldosterone Syst. 2012 Mar; 13(1):118-21.